Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Many transgender men on testosterone therapy experience hair loss.

A new method effectively predicts estrogen-related health effects for early screening.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Balding hair follicles have reduced growth factors and increased inhibitory factors, suggesting new treatment paths for hair loss.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

The Itpr3 gene causes a specific hair pattern in mice.

The hair tonic with menthol grew longer hair, but both formulas had similar overall hair growth.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Hirsutism greatly lowers the quality of life for Turkish women.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Troxerutin helps protect skin cells from oxidative stress and may be good for treating hair loss.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Higher CSF 5-HIAA levels may predict better response to serotonin re-uptake inhibitors in trichotillomania.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.